Current evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndrome.
about
Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in KoreaShiga Toxin (Stx) Classification, Structure, and FunctionAn international consensus approach to the management of atypical hemolytic uremic syndrome in children.HUS and atypical HUS.Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study.
P2860
Current evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndrome.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Current evidence for the role ...... n haemolytic uraemic syndrome.
@ast
Current evidence for the role ...... n haemolytic uraemic syndrome.
@en
type
label
Current evidence for the role ...... n haemolytic uraemic syndrome.
@ast
Current evidence for the role ...... n haemolytic uraemic syndrome.
@en
prefLabel
Current evidence for the role ...... n haemolytic uraemic syndrome.
@ast
Current evidence for the role ...... n haemolytic uraemic syndrome.
@en
P2860
P1433
P1476
Current evidence for the role ...... n haemolytic uraemic syndrome.
@en
P2093
Lindsay S Keir
Moin A Saleem
P2860
P2888
P304
P356
10.1007/S00467-013-2561-1
P577
2013-07-11T00:00:00Z
P5875
P6179
1051563400